Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$353.56
3.430.98%
Last update: Oct 9, 11:04 AM
$344.72
-5.41-1.55%
BeOne Medicines Ltd (ONC) Stock Price, Quote, News & History
ONCNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of non-Hodgkin...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BeOne Medicines (NASDAQ:ONC) through any online brokerage.
Other companies in BeOne Medicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
BeOne Medicines has a consensus price target of $387.40.
The stock price for BeOne Medicines (NASDAQ: ONC) is $353.56 last updated October 9, 2026 at 11:04 AM EDT.
There are no upcoming dividends for BeOne Medicines.
BeOne Medicines does not have any upcoming earnings scheduled.
There is no upcoming split for BeOne Medicines.
BeOne Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
